A guide written by Dr. Antonio Moffa, Dr. Claudia Beccaria and Lucrezia Giorgi of the Unit of Integrated Therapies in Otolaryngology at the University Polyclinic Campus Bio-Medical Foundation in Rome.
In the five-year period 2016-2020, an average of about 1,500 workers per year were recognised as having an asbestos-related disease. In the same years, around 50% of workers who contracted asbestos-related diseases suffered a permanent impairment of no more than 25%, while 37% of technopaths died as a result of the occupational disease. Specifically in 2016, the proportion of workers with an impairment of no more than 25 per cent remained almost unchanged, but those with a fatal outcome rose to 43 per cent.
The use of asbestos was banned in Italy in 1992 with Law No. 257, which set the terms and procedures for the cessation of all activities involving the processing and extraction of this mineral. After this date, the only permitted work activities involving exposure to asbestos are its clearance, removal and disposal.
The IARC (International Agency for Research on Cancer) has classified asbestos as a human carcinogen (Group 1).
The danger of asbestos derives from the degree of fibre freedom, i.e. the ability of asbestos-containing materials to release potentially inhalable fibres into the air. Since asbestos is a friable and fibrous material, it is easy for very small particles to be released into the air as a result of any type of stress (processing and handling, vibrations, infiltration of humidity), which, once inhaled, are capable of being deposited in the pulmonary alveoli, bronchi and pleura, causing irreversible tissue damage and the onset of pulmonary diseases. Moreover, as there is no risk threshold below which the concentration of asbestos fibres in the air is not dangerous, it follows that the inhalation of even a single fibre can cause fatal pathologies; clearly, prolonged exposure over time or to high quantities will exponentially increase the likelihood of contracting such pathologies.
The European Commission has recently approved an exposure limit value (or TLV) 10 times lower than the previous one (0.1 fibres/cm3), i.e. 0.01 fibres/cm3, for an 8-hour exposure reference. The harmful effects that occur following the inhalation of asbestos particles are derived from pathogenic mechanisms of an irritative, degenerative and carcinogenic nature and can lead to the onset of various diseases.
The pathologies resulting from breathing in asbestos fibres are all characterised by a long interval between the start of exposure and the appearance of the first symptoms of the disease: this interval, termed 'latency time', can generally last up to decades.
From these pathologies related to exposure to asbestos derives the importance of worker protection, which must be on several fronts: the worker must be equipped with personal respiratory protective equipment with an operational protection factor that ensures that the filtered air inside the PPE is no more than 1/10 of the limit value. The use of PPE must also be interspersed with rest periods appropriate to the physical effort required by the work, and the employer must carry out periodic measurements of the concentration of fibres in the air, reporting the results in the DVR (Risk Assessment Document).
Recommended products:
Giornata Mondiale della Terra 2022 Dalla prima Giornata Mondiale della Terra nel 1970 il movimento per il futuro del pianeta ha fatto passi da gigante. Eppure, purtroppo, i problemi legati ai rifiuti e all'inquinamento ambientale stanno aumentando. In certe aree respirare è diventato dannoso per la salute. La nostra casa sta soffrendo. BLS condivide da […]
Scopri tutti i momenti più importanti Il 2022 ha sancito l'inizio della partnership tra BLS Group e il team di Monster Energy Yamaha MotoGP. Celebriamo l'anno passato condividendo tutti i momenti salienti che hanno scandito la partnership condivisa tra due campioni in sicurezza: BLS Group e il team Monster Energy Yamaha MotoGP. Siamo orgogliosi di […]
With a filtering capacity of more than 94% for FFP2 and more than 99% for FFP3, the new BLS 502 and BLS 503 masks are DPI without valves, CE certified according to European regulation 2016/425 and technical standard EN 149: 2001, able to protect users in the event of exposure to solid and/or liquid non-volatile particles (dust, fumes, mists) and to block the dispersion of viruses both incoming and outgoing. They are, in fact, sealed on the face and manufactured with a "welding” process, without seams and perforations on the fabric from which micro particles could pass, thus creating a barrier during exhaling, protecting the environment from the user of the mask. These masks are therefore ideal for use in the food & beverage and medical sectors, as well as in all work environments where contamination by the user must be avoided.
